NCT01743950 2026-03-25A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With BevacizumabUniversity of Wisconsin, MadisonPhase 2 Terminated49 enrolled 19 charts
NCT03690869 2025-04-08REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent GliomaRegeneron PharmaceuticalsPhase 1/2 Terminated57 enrolled 31 charts